CVI Holdings
DMK

CVI Holdings’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

CVI Holdings’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-48,542
Closed -$1.21M – 81
2020
Q1 		$1.21M Buy
+48,542
New +$2.06M 4.26% 6
2019
Q4 		– Sell
-12,620
Closed -$622K – 49
2019
Q3 		$622K Buy
+12,620
New +$907K 1.4% 15

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Level Four Advisory Services
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return

CVI Holdings's DMK Position: Q2 2020 in Review

CVI Holdings sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2020, closing a stake of 48,542 shares — an estimated $1.21M sold.

CVI Holdings first reported a position in DMK in Q3 2019 and held it in 2 quarters. The position peaked at $1.21M in Q1 2020. 47 funds tracked by Wall St. Rank hold DMK as of Q2 2020.

  • CVI Holdings reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2020 after selling out during the quarter.
  • CVI Holdings sold 48,542 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2020, an estimated $1.21M.
  • CVI Holdings first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2019 and held it in 2 quarters.
  • CVI Holdings's DMK Pharmaceuticals Corporation Common Stock position peaked at $1.21M in Q1 2020.
  • 47 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2020.

Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.